Advertisement
Screener

Autolus Therapeutics plc (AUTL) Auditor

Autolus Therapeutics plc Auditor

The independent registered public accounting firm that signed the audit report in each annual report on Form 10-K, newest first. PCAOB firm ID and the internal-control attestation are as tagged on the cover from fiscal 2021; earlier rows come from the signed report text.

  • 2026-03-27: Fiscal year end 2025-12-31; Auditor Ernst & Young LLP; PCAOB firm ID 1438; Location Reading, United Kingdom.
  • 2025-03-20: Fiscal year end 2024-12-31; Auditor Ernst & Young LLP; PCAOB firm ID 1438; Location Reading, United Kingdom.
  • 2024-03-21: Fiscal year end 2023-12-31; Auditor Ernst & Young LLP; PCAOB firm ID 1438; Location Reading, United Kingdom.
FiledFiscal year endAuditorPCAOB firm IDLocationInternal-control attestation
2026-03-272025-12-31Ernst & Young LLP1438Reading, United KingdomNo
2025-03-202024-12-31Ernst & Young LLP1438Reading, United KingdomNo
2024-03-212023-12-31Ernst & Young LLP1438Reading, United KingdomNo

Similar stocks

Stock NameCountryMarket CapPE Ratio
Entera Bio Ltd. (ENTX)$0.485B
REGENXBIO Inc. (RGNX)United States$0.477B-3.30
Tectonic Therapeutic, Inc. (TECX)United States$0.469B-7.68
Prime Medicine, Inc. (PRME)United States$0.557B-3.54
Eikon Therapeutics, Inc. (EIKN)United States$0.446B
Allogene Therapeutics, Inc. (ALLO)United States$0.574B-4.33
Kyverna Therapeutics, Inc. (KYTX)United States$0.434B-3.60
Editas Medicine, Inc. (EDIT)United States$0.424B-4.29
Scribe Therapeutics, Inc. (SCTX)United States$0.410B
Zura Bio Ltd (ZURA)$0.398B-6.56